Tops & Flops Stocks
Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Heron Therapeutics Inc. | 21.840% | -5.499% | -5.362% | 11.624% | 66.369% | -81.747% | - |
F-Star Therapeutics Inc. | 18.750% | - | - | - | - | - | - |
ImmunityBio Inc. | 16.620% | -8.629% | -20.354% | 102.703% | -4.661% | -70.960% | - |
Ziopharm Oncology | 11.930% | - | - | - | - | - | - |
Strata Skin Sciences Inc. | 11.660% | 6.699% | 12.060% | -55.842% | -8.607% | -69.028% | -82.153% |
Corvus Pharmaceuticals Inc | 11.130% | -2.413% | -21.098% | 36.931% | -14.868% | -43.739% | -67.487% |
BioScrip Inc. | 9.810% | - | - | - | - | - | - |
Alimera Sciences | 9.190% | - | - | - | - | - | - |
Healthstream Inc. | 9.010% | -2.632% | -7.500% | -9.756% | -7.500% | 20.000% | -2.738% |
SCYNEXIS Inc. | 7.640% | 5.366% | 13.339% | -46.777% | -25.943% | -76.023% | - |
Bastide Le Confort | 7.520% | -1.154% | -7.554% | -45.027% | -44.231% | -67.016% | - |
Infinity Pharmaceuticals Inc. | 7.360% | - | - | - | - | - | - |
Athersys Inc. | 6.990% | - | - | - | - | - | - |
Syros Pharmaceuticals Inc. | 6.840% | -8.190% | -17.182% | 89.020% | -26.970% | -91.156% | - |
Glycomimetics Inc. | 6.770% | -14.581% | -36.367% | 36.107% | -23.274% | -17.429% | - |
Seaspine Holdings Corp | 6.670% | - | - | - | - | - | - |
Pacific Biosciences of California Inc. | 5.800% | -3.121% | -63.057% | -87.104% | -86.477% | -95.051% | -80.841% |
Enlivex Therapeutics Ltd. | 5.690% | -13.986% | -63.393% | -53.409% | -45.089% | -84.815% | - |
BeiGene Ltd ADR | 5.690% | 4.839% | -13.907% | -44.444% | -21.212% | -50.758% | - |
Capricor Therapeutics Inc | 5.440% | -16.071% | -20.474% | 21.290% | 5.028% | 45.062% | - |
Nymox Pharmaceutical Corp. | 5.410% | - | - | - | - | - | - |
Corcept Therapeutics Inc. | 5.110% | -0.186% | -5.702% | 4.369% | -28.333% | 8.040% | - |
Rocket Pharmaceuticals Inc | 5.090% | -0.523% | 0.113% | 35.591% | -4.654% | -41.601% | 76.124% |
Eidos Therapeutics | 5.050% | - | - | - | - | - | - |
Simulations Plus | 4.290% | - | - | - | - | - | - |